Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Oct 25, 2022

SELL
$0.12 - $1.31 $21,360 - $233,180
-178,000 Reduced 71.66%
70,400 $1,000
Q2 2022

Aug 04, 2022

SELL
$0.81 - $2.53 $91,530 - $285,890
-113,000 Reduced 31.27%
248,400 $21,000
Q1 2022

Apr 14, 2022

SELL
$2.53 - $3.9 $48,322 - $74,490
-19,100 Reduced 5.02%
361,400 $92,000
Q4 2021

Jan 18, 2022

BUY
$3.27 - $6.38 $54,282 - $105,908
16,600 Added 4.56%
380,500 $302,000
Q3 2021

Oct 26, 2021

BUY
$5.11 - $10.81 $1.39 Million - $2.93 Million
271,500 Added 293.83%
363,900 $210,000
Q2 2021

Jul 19, 2021

BUY
$6.7 - $11.98 $124,620 - $222,828
18,600 Added 25.2%
92,400 $82,000
Q1 2021

Apr 26, 2021

BUY
$2.51 - $6.96 $185,237 - $513,648
73,800 New
73,800 $83,000

About 180 Life Sciences Corp.


  • Ticker ATNF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,698,900
  • Market Cap $70.5M
  • Description
  • 1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on f...
More about ATNF
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.